Deborah Keller

Laboratory Corporation of America has named Deborah Keller as the CEO of Covance Drug Development. She takes over for Joseph Herring who will retire on July 31 after more than a decade as CEO.

Keller joined Covance in 1987 and has held senior leadership roles in global operations, quality assurance, and marketing. Most recently she served as executive vice president of Covance and group president of R&D Laboratories where she led more than 6,000 employees at 18 facilities across the globe.